Issues lobbied + lobbyists
HCR — Health Issues
Discussions related to costs incurred by Medicare & Medicaid for treatment of smoking related diseases; public impact of smoking related diseases and the potential cost savings and improved public health outcomes related to tobacco harm reduction programs and products.
Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE; Veterans Affairs, Dept of (VA)
BUD — Budget/Appropriations
H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; provisions related to reform of the Food and Drug Administration S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; provisions related to reform of the Food and Drug Administration
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
FOR — Foreign Relations
Discussions related to U.S. policy guidance provided to executive branch personnel regarding foreign government engagements. Discussions related to foreign contractual matters. Discussions related to foreign environmental certifications.
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE; State, Dept of (DOS)
DEF — Defense
Discussions related to tobacco harm reduction on military installations. Discussions related to educating adult smokers about smoke-free products, the continuum of risk, and misconceptions about nicotine.
Government entities lobbied: Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; SENATE
TAX — Taxation/Internal Revenue Code
Discussions related to the federal excise tax on ethanol and its application to manufacturing of tobacco products.
Government entities lobbied: Alcohol & Tobacco Tax & Trade Bureau (TTB)
TOB — Tobacco
Discussions related to implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act. Discussions related to the importance of tobacco harm reduction and the availability of FDA-authorized smoke-free products. Discussions related to educating adult smokers about smoke-free products, the continuum of risk, and misconceptions about nicotine. Discussions related to efforts to address smoking rates in certain populations where there has not been a meaningful decline. Discussions related to enforcement of illicit tobacco products, including importation and distribution of counterfeit products. Discussions related to user fees for tobacco product and nicotine products. Discussions related to efforts to prevent underage access to tobacco products. Discussions related to reforms of the Food and Drug Administrations Center for Tobacco Products. Discussions related to PMTA and MRTPA submissions and FDA authorization of scientifically-substantiated products. Discussions related to the misperception of nicotine in the context of tobacco policy and public health.
Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD); Executive Office of the President (EOP); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE; Veterans Affairs, Dept of (VA)
TRD — Trade (domestic/foreign)
Discussions related to potential tariffs on imported products. Discussions related to non-tariff barriers to trade and related foreign trade issues. Discussions related to foreign environmental certification.
Government entities lobbied: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; State, Dept of (DOS); U.S. Trade Representative (USTR)
VET — Veterans
Discussions related to Veterans and health related issues.
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE